Skip to content

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

16 recorded connections shown. Select a record, office or person to follow its source references.

Start with
and connect to

Browse all held record sources

Zoom to read. Drag to explore. Select a connection.

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Bills · As of Sep 23, 2026

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.: 15 incoming connections shown and 1 outgoing connections shown. Point at anyone to see how they are linked.Showing bounded source connections. Dates come from the held records; missing relationships remain unknown.

The source record

As of Sep 23, 2026.

Congress
119
Bill type
hr
Bill number
679
Title
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Introduced date
2025-01-23
Latest action date
2025-01-23
Latest action text
Referred to the House Committee on Energy and Commerce.
Origin chamber
house
Policy area
Health
Url
https://www.congress.gov/bill/119th-congress/house-bill/679
Became law
false
Created at
2026-05-18T05:36:59.839253
Updated at
2026-09-23T23:08:10.495164
Open the official source